Ziprasidone hydrochloride

This classification denotes an antipsychotic agent with the molecular formula C21H21ClN4OS.ClH.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 216X081ORU, chemically known as 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-2-indolinone monohydrochloride, monohydrate but more generally known as ziprasidone hydrochloride, which bears US NIH Compound Identifier 60853. European Medicines Agency schedules Ziprasidone hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05189MIG. Most nations, for tariff and trade purposes, schedule ziprasidone hydrochloride under HS 29341000 and SITC 51579. As of Q4 2014, ZIPRASIDONE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Ziprasidone hydrochloride bears US NLM identifiers UMLS ID C0380392 and NCI Concept Code C48031. SMILES: C1CCC2C(C1)C(NS2)N3CCN(CC3)CCC4CC5C(CC4CL)NC(=O)C5.O.CL.